T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy - Wikidata - wikimedia - TriplyDB

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

http://www.wikidata.org/entity/Q37160724

about

The embryological basis of subclinical hypertrophic cardiomyopathy Research priorities in sarcomeric cardiomyopathies Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.The systolic paradox in hypertrophic cardiomyopathy.Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy.Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.Integrating Genetics and Medicine: Disease-Modifying Treatment Strategies for Hypertrophic Cardiomyopathy.Myocardial tissue remodeling in adolescent obesity Myocardial T1 and T2 Mapping: Techniques and Clinical Applications.The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.Genetics and genomics of dilated cardiomyopathy and systolic heart failure.Role of cardiac MRI in diabetes.Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation?Myocardial T1 mapping: modalities and clinical applications.Genetic biomarkers in hypertrophic cardiomyopathy.Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure.Almanac 2014: cardiomyopathies.Individualized cardiovascular risk assessment by cardiovascular magnetic resonance.T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.The genetic basis of hypertrophic cardiomyopathy in cats and humans.Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.Using genetic testing to guide therapeutic decisions in cardiomyopathy.Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.Role of T1 Mapping in Inherited Cardiomyopathies.The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy

P2860

Q27342687-2C478624-AFE3-440D-B413-2A2F41016454 Q27694507-94C92CBE-F265-4612-A895-26329CC61677 Q30278822-827C1A63-3C09-4B66-B8A9-6C09756F170D Q30421950-B2CE9A83-9139-4477-951A-8A3E81BA30E0 Q30867239-2C7994CC-55C2-4980-AC66-3D985D0254DE Q33554999-97BD7E49-2DC8-46CB-B295-855F596A915D Q33595504-E50A9361-6F7F-4035-A73C-16817FE8129B Q33764571-36A783FB-D797-4DAE-9CF7-56D3A84B0851 Q33801809-0A4BA6D9-95B5-46D2-8838-FCF0D3CEC3EE Q34543914-C9FB1617-E32F-4495-8E2A-BD6CE299B1CA Q35899352-E089F3B9-6E47-44F7-AB8E-712586FDA11D Q36026885-7E4FCDD2-E52E-46A5-BC6D-7AD5CC727FBB Q36305091-279066B1-8AAB-46A1-8FA3-197A706780AF Q36826251-6A97388D-6E29-4784-B5A1-C910A3D4E238 Q36851346-9AFF1E7A-D354-41AB-8B85-0B4BCF3781B8 Q36888254-AC400BCB-E412-415C-BA6B-60F9392371FC Q37310497-D903BFCE-90AB-4DB8-9AC3-037AD30DBAE7 Q37589574-BF6E8196-5850-4AE6-83CF-228349AD1617 Q37596065-F4F645CF-7304-4293-A5AC-7DEBD7211513 Q37652430-03F7BD5B-1212-4D1F-B54B-F08B7EB37BA9 Q37661546-70ABA618-ABA7-4FF8-A9D5-082158320D60 Q37662894-1CAA9462-7CDA-401C-B3DC-E1A037350FB1 Q37683177-273B2E1E-FD4B-44B6-9450-4502D20C8D97 Q37696227-73A6ABAD-5B28-4FFE-B62E-E73A9D494D4C Q37717684-14D6AB40-1354-4CA4-9F6A-7FA078E133AE Q38125765-39E50919-0F4F-4BEC-B4E7-FECF60B393A0 Q38171866-95433CB6-A487-4F04-8BD0-EB06B74160DA Q38193960-07956259-B7D7-43C0-83D2-E5302C0CB797 Q38206843-E73EB4A7-6481-4D51-8A93-0BD6A7A37E32 Q38270769-08ED4AC1-F597-454E-A8EC-0B8AA0815D62 Q38336102-17678BDD-B24E-49AF-8938-984546A968FC Q38699748-7DEAE876-63E9-42C3-B60F-D89ADB492188 Q38863215-8338D059-F06F-40EA-85A7-4544EDD0F087 Q39370604-D1DB2518-4A8A-42FF-9EB6-36620F7EF5D9 Q39398133-EBE34BE9-9E74-4254-9736-240CC8763ACC Q40458508-2B74F5C8-D348-4C43-8458-9E11264663B2 Q41101323-E409EFD0-02E2-41CF-A782-8382920F6BDA Q41439031-4FED449E-C7AE-429D-8FCD-4C8FD9B30894 Q41626761-17442E8C-545A-4F01-9EF7-C55976283835 Q42278868-1C757A93-9851-4CD9-85AA-AFF34642A5B4

P2860

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

http://www.wikidata.org/entity/Q37160724

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

T1 measurements identify extra ...... t left ventricular hypertrophy

@en

T1 measurements identify extra ...... left ventricular hypertrophy.

@nl

type

label

T1 measurements identify extra ...... t left ventricular hypertrophy

@en

T1 measurements identify extra ...... left ventricular hypertrophy.

@nl

prefLabel

T1 measurements identify extra ...... t left ventricular hypertrophy

@en

T1 measurements identify extra ...... left ventricular hypertrophy.

@nl

P1433

Q37160724-0C72F4E0-662C-492F-A181-14F574E6CC4D

P1476

Q37160724-CF655CED-D8D3-4A8A-A4EB-C25A1A6A1919

P2093

Q37160724-03F9BC81-9619-4373-9B77-FDFBFDD4BFDE

Q37160724-0A268E94-27F8-4DE9-81F4-4BC1242B4F6B

Q37160724-0E1B2DA7-7D76-4BB4-8631-99A49E8291CE

Q37160724-1E21E867-F6F0-438F-B859-8A80D28E7FCA

Q37160724-4F2F9590-CD17-4ED3-A1C3-C1D27B632B0A

Q37160724-8AE762BD-2277-4979-94B6-4D4B51A4FCAB

Q37160724-94491506-EE03-4884-AE37-F3D5E36EE5A2

Q37160724-CEB39A3A-7BFE-427A-BE06-C2C90C88F6AC

Q37160724-E029B536-9447-4C6C-8B8C-78CB14E1F81D

Q37160724-F51F0671-A61A-4719-BCFD-C4D205365C38

P2860

Q37160724-09124E56-5571-4602-82FE-B98F44BBB648

Q37160724-1BCC765D-B851-4444-806A-C5790753194B

Q37160724-1BEC77D3-CD19-4CFC-A460-E5E4129549B5

Q37160724-1E3FB4BA-8FA6-4A70-97ED-11A68CDB1BC6

Q37160724-2A967C11-7CD3-408D-AE3E-81ABB7C592D9

Q37160724-310CA4CA-87AC-4E26-AEE1-6A955D308FB3

Q37160724-3240D82A-F1A4-4181-99EC-6CAEADB775CB

Q37160724-368C26A6-7B46-416F-800B-8421EF16E647

Q37160724-39EE2344-2A29-4BB7-98AB-DAB90B61540A

Q37160724-3ABB5021-A768-4600-A623-A8FB12B5CED6

P304

Q37160724-B6814446-EAF5-4739-BCAC-03131C5AE7F3

P31

Q37160724-4D3B50F4-2397-4A55-9760-7CF5D8515BE4

P356

Q37160724-626D9899-60C1-472E-B82C-5F1AD73103F4

P433

Q37160724-E5FF7AFF-B30F-4890-8FE0-311F38AF0A7A

P478

Q37160724-851EC7F3-688D-4410-BEC8-D103813C1A01

P50

Q37160724-66371A20-88EA-45DB-8C94-018B907B1554

Q37160724-B88C2D68-4156-4771-9401-C5586BE0EDE9

Q37160724-BFD07BA6-60D7-4DDB-A78D-E81201853707

Q37160724-DC571EC4-78B6-4CD7-B936-3538A2CCC521

P577

Q37160724-B6AB73D2-62BF-4CE9-83C5-F0D97864AB6F

P698

Q37160724-AA2BC005-24B6-4444-BA50-393E7BBA4D01

P932

Q37160724-18A7C9DE-40F0-48B4-A1BC-E3A3F195B7E8

P356

CIRCIMAGING.112.000333

P1433

Circulation: Cardiovascular Imaging

P1476

T1 measurements identify extra ...... t left ventricular hypertrophy

@en

P2093

Allison L Cirino

http://www.w3.org/2001/XMLSchema#string

Arantxa González

http://www.w3.org/2001/XMLSchema#string

Bobak Heydari

http://www.w3.org/2001/XMLSchema#string

E John Orav

http://www.w3.org/2001/XMLSchema#string

Javier Díez

http://www.w3.org/2001/XMLSchema#string

Neal K Lakdawala

http://www.w3.org/2001/XMLSchema#string

Ravi V Shah

http://www.w3.org/2001/XMLSchema#string

Raymond Y Kwong

http://www.w3.org/2001/XMLSchema#string

Tomas G Neilan

http://www.w3.org/2001/XMLSchema#string

Yucheng Chen

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

The Genetic Basis for Cardiomyopathy

Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy

An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction.

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy.

Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

P304

415-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCIMAGING.112.000333

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Siddique A. Abbasi

Michael Jerosch-Herold

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23549607

http://www.w3.org/2001/XMLSchema#string

P932

3769196

http://www.w3.org/2001/XMLSchema#string